According to the latest report by IMARC Group, titled “Immunoassay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on immunoassay market outlook. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global immunoassay market size reached US$ 27.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 39.9 Billion by 2027, exhibiting a growth rate (CAGR) of 6.4% during 2022-2027.
Immunoassay is the bioanalytical technique conducted to determine the concentration of macromolecule in a solution using an antibody or immunoglobulin. It is used to measure the number of analytes in serum and urine for medical and research purposes. It is also used in qualitative, quantitative, and radioactivity procedures to ensure test results accuracy. It uses the property of affinity of antigen-antibody to distinguish and measure molecules of interest in biological samples.
Request to Get the Free Sample Report: https://www.imarcgroup.com/immunoassay-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Global Immunoassay Market Trends:
The global market is majorly driven by the increasing need for disease diagnostics. In line with this, rising research and development activities and therapeutic drug monitoring are positively influencing the market. Furthermore, a considerable rise in clinical research practices, escalation in incidences, and the prevalence of infectious diseases are other growth-inducing factors. Moreover, the growing geriatric population, which is more prone to chronic and infectious diseases, is catalyzing the market. Besides this, the prevalence of chronic conditions, such as cancer, infections, cardiovascular diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases, has led to the widespread usage of immunoassay techniques in disease diagnostics. Additionally, multiple market players are introducing automated laboratory systems and point-of-care compact, portable assay tests, thus providing a boost to the growth of the market.
Explore Full Report with Table of Contents:
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
- Abbott
- Becton Dickinson and Company
- BioMérieux SA
- Danaher Corporation
- Merck KGaA
- PerkinElmer Inc
- Quidel Corporation
- Siemens Healthcare Pty Ltd (Siemens AG)
- Sysmex Corporation
- Thermo Fisher Scientific
Immunoassay Market Segmentation:
Our report has categorized the market based on region, technology, product, application and end use.
Market Breakup by Technology:
- Radioimmunoassay
- Enzyme Immunoassay
- Rapid Test
- Others
Market Breakup by Product:
- Reagents and Kits
- Analyzers/Instruments
- Software and Services
Market Breakup by Application:
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
Market Breakup by End Use:
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
